Clinical trial
Alternative Treatment to Reduce Chronicity in OCD: Research Into Brain Response and Adequacy of Treatment A Randomized Controlled Non-inferiority Trial Into the Effectiveness and Working Mechanisms of IBA in Comparison to CBT.
NCT03929081 is registered in ClinicalTrials.gov with GGZ Centraal as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alternative Treatment to Reduce Chronicity in OCD: Research Into Brain Response and Adequacy of Treatment A Randomized Controlled Non-inferiority Trial Into the Effectiveness and Working Mechanisms of IBA in Comparison to CBT.
- Lead sponsor
- GGZ Centraal
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 20, 2019
- Completion date
- October 17, 2023
- Enrollment
- 246 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.